Beacon Biosignals
Beacon Biosignals is an AI-driven neurotechnology company focused on accelerating drug development for neurological and psychiatric conditions. Their end-to-end platform utilizes FDA-cleared EEG headbands and AI-powered analytics to collect and analyze brain data, providing novel biomarkers for clinical trials. The platform includes the Waveband EEG headband for data collection, the Beacon Datastore for data storage and analysis, Beacon HQ for trial management, and comprehensive Clinical Study Operations and Scientific Services. Beacon aims to improve trial accuracy, patient stratification, and support expanded labeling claims for new treatments, ultimately getting life-changing therapies to patients faster. Their technology supports translational research, clinical trial optimization, and clinical practice by extracting meaningful insights from EEG data.
Beacon Biosignals
Beacon Biosignals is an AI-driven neurotechnology company focused on accelerating drug development for neurological and psychiatric conditions. Their end-to-end platform utilizes FDA-cleared EEG headbands and AI-powered analytics to collect and analyze brain data, providing novel biomarkers for clinical trials. The platform includes the Waveband EEG headband for data collection, the Beacon Datastore for data storage and analysis, Beacon HQ for trial management, and comprehensive Clinical Study Operations and Scientific Services. Beacon aims to improve trial accuracy, patient stratification, and support expanded labeling claims for new treatments, ultimately getting life-changing therapies to patients faster. Their technology supports translational research, clinical trial optimization, and clinical practice by extracting meaningful insights from EEG data.
